Imrecoxib
- Generic Name
- Imrecoxib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H23NO3S
- CAS Number
- 395683-14-4
- Unique Ingredient Identifier
- SGW6W5758V
- Background
Imrecoxib has been used in trials studying the treatment of Knee Osteoarthritis.
- Indication
用于缓解骨关节炎的疼痛症状，适用于男性及治疗期间无生育要求的妇女。
- Associated Conditions
- -
- Associated Therapies
- -
A Multicenter，Double-Blind and Randomized Controlled Trial of Fengshigutong Capsule in the Treatment of Ankylosing Spondylitis
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2019-04-30
- Last Posted Date
- 2019-04-30
- Lead Sponsor
- Sun Yat-sen University
- Target Recruit Count
- 180
- Registration Number
- NCT03932006
- Locations
- 🇨🇳
Rheumatology Department, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Pharmacokinetics of Imrecoxib in Subjects With Hepatic Insufficiency
- First Posted Date
- 2015-05-28
- Last Posted Date
- 2015-05-28
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT02456688
- Locations
- 🇨🇳
The frist affiliated hospital of Fourth Military Medical University, Xi'an, Shanxi, China
A Drug Drug Interaciton Study of Imrecoxib and Warfarin in Healthy Volunteers
- First Posted Date
- 2015-04-24
- Last Posted Date
- 2015-04-24
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT02426060
- Locations
- 🇨🇳
Union Hospital Tongji Medical College Huazhong University of Science and technology, Wuhan, Hubei, China
A Phase 4 Study of Imrecoxib in Treatment of Knee Osteoarthritis
- First Posted Date
- 2013-11-15
- Last Posted Date
- 2013-11-15
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 2400
- Registration Number
- NCT01985165
- Locations
- 🇨🇳
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
🇨🇳The Second Hospital of Shangdong University, Jinan, Shandong, China
🇨🇳Taizhou Hospital, Taizhou, Zhejiang, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath